Immunopathology in ocular toxoplasmosis: Facts and clues

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 2, 2009, Pages 211-220

  Garweg, Justus G ^a   Candolfi, Ermanno ^b  

^a Swiss Eye Institute   (Switzerland)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Acquired toxoplasmosis; Chemokines; Congenitally contracted toxoplasmosis; Cytokines; Experimental autoimmune uveitis; Ocular toxoplasmosis

Indexed keywords

EID: 65549146491     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000200014     Document Type: Article

References (91)

1. Afzali B, Lombardi G, Lechler RI, Lord GM 2007. The role of T helper 17 (T(H)-17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148: 32-46.
2. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE 2007. T(H)-17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: 711-718.
3. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL 2007. A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells. Nat Immunol 8: 1380-1389.
4. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7: 929-936.
5. Benedetto N, Folgore A, Romano Carratelli C, Galdiero F 2001. Effects of cytokines and prolactin on the replication of Toxoplasma gondii in murine microglia. Eur Cytokine Netw 12: 348-358.
6. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK 2006. Reciprocal developmental pathways for the generation of pathogenic effector T(H)-17 and regulatory T cells. Nature 441: 235-238.
7. Bettelli E, Oukka M, Kuchroo VK 2007 T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8: 345-350.
8. Calabrese KS, Tedesco RC, Zaverucha do Valle T, Barbosa HS 2008. Serum and aqueous humour cytokine response and histopathological alterations during ocular Toxoplasma gondii infection in C57BL/6 mice. Micron 39: 1335-1341.
9. Caspi RR 2006. Ocular immunity: price of privilege. Immunol Res 213: 23-35.
10. Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest 116: 1317-1326.
11. Cogan DG 1977. Immunosuppression and eye disease. First vail lecture. Am J Ophthalmol 83: 777-788.
12. Cordeiro CA, Moreira PR, Andrade MS, Dutra WO, Campos WR, Oréfice F, Teixeira AL 2008. Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol Vis Sci 49: 1979-1982.
13. Cordoba-Rodriguez R, Frucht DM 2003. IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin Biol Ther 3: 715-723.
14. Deckert M, Lütjen S, Leuker CE, Kwok LY, Strack A, Müller W, Wagner N, Schlüter D 2003. Mice with neonatally induced inactivation of the vascular cell adhesion molecule-1 fail to control the parasite in Toxoplasma encephalitis. Eur J Immunol 33: 1418-1428.
15. Deckert-Schlüter M, Buck C, Weiner D, Kaefer N, Rang A, Hof H, Wiestler OD, Schlüter D 1997. Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J Neuroimmunol 76: 167-176.
16. Dong C 2006. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing (T(H)-17) cells. Nat Rev Immunol 6: 329-333.
17. Esterre P 1996. Immune reactions in the brain. Arch Inst Pasteur Madagascar 63: 24-30.
18. Fatoohi F, Cozon GJ, Wallon M, Kodjikian L, Peyron F 2006. Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis. Jpn J Ophthalmol 50: 103-110.
19. Feron EJ, Klaren VN, Wierenga EA, Verjans GM, Kijlstra A 2001. Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis. Invest Ophthalmol Vis Sci 42: 3228-3232.
20. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A 2007. Suppressive effect of IL-27 on encephalitogenic T(H)-17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 179: 3268-3275.
21. Forrester JV, Stott DI, Hercus KM 1989. Naturally occurring antibodies to bovine and human retinal S antigen: a comparison between uvei- tis patients and healthy volunteers. Br J Ophthalmol 73: 155-159.
22. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR 2007. Autoimmune inflammation from the T(H)-17 perspective. Autoimmun Rev 6: 169-175.
23. Gaddi PJ, Yap GS 2007. Cytokine regulation of immunopathology in toxoplasmosis. Immunol Cell Biol 85: 155-159.
24. García H, Dante C, Calderon G, Antonio P 1988. Production of specific retinal S antigen antibodies in patients with retinal detachment. Graefes Arch Clin Exp Ophthalmol 226: 428-430.
25. Gazzinelli RT, Brézin A, Li Q, Nussenblatt RB, Chan CC 1994. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma. Exp Parasitol 78: 217-229.
26. Gocke AR, Cravens PD, Ben LH, Hussain RZ, Northrop SC, Racke MK, Lovett-Racke AE 2007. T-bet regulates the fate of T(H)-1 and T(H)-17 lymphocytes in autoimmunity. J Immunol 178: 1341-1348.
27. Gonçalves RM, Rodrigues DH, Camargos da Costa AM, Teixeira MM, Ribeiro Campos W, Oréfice F, Teixeira AL 2007. Increased serum levels of CXCL8 chemokine in acute toxoplasmic retinochoroiditis. Acta Ophthalmol Scand 85: 871-876.
28. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT 2005. Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
29. Hay J, Hutchison WM, Lee WR, Siim JC 1981. Cataract in mice congenitally infected with Toxoplasma gondii. Ann Trop Med Parasitol 75: 455-457.
30. Hay J, Lee WR, Dutton GN, Hutchison WM, Siim JC 1984. Congenital toxoplasmic retinochoroiditis in a mouse model. Ann Trop Med Parasitol 78: 109-116.
31. Hoekzema R, Hwan SB, Rothova A, van Haren MA, Donoso LA, Kijlstra A 1990. Serum antibody response to human and bovine IRBP in uveitis. Curr Eye Res 9: 1177-1183.
32. Hu MS, Schwartzman JD, Yeaman GR, Collins J, Seguin R, Khan IA, Kasper LH 1999. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immun 67: 928-935.
33. Hunter CA 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5: 521-531.
34. Hutchison WM, Hay J, Lee WR, Siim JC 1982. A study of cataract in murine congenital toxoplasmosis. Ann Trop Med Parasitol 76: 53-70.
35. Ifergan I, Kébir H, Bernard M, Wosik K, Dodelet-Devillers A, Cayrol R, Arbour N, Prat A 2008. The blood-brain barrier induces differentiation of migrating monocytes into T(H)-17-polarizing dendritic cells. Brain 131: 785-799.
36. Iwakura Y, Ishigame H 2006. The IL-23/IL-17 axis in inflammation. J Clin Invest 116: 1218-1222.
37. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, Wilson M, Wynn TA, Kamanaka M, Flavell RA, Sher A 2007. Conventional T-bet(+)Foxp3(-) T(H)-1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
38. Ke Y, Jiang G, Sun D, Kaplan HJ, Shao H 2008. Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis. Invest Ophthalmol Vis Sci 49: 3999-4007.
39. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A 2007. Human T(H)-17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13: 1173-1175.
40. Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, Combe C, Moretto M, Khan IA 2005. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73: 617-621.
41. Kijlstra A, Hoekzema R, vd Lelij A, Doekes G, Rothova A 1990. Humoral and cellular immune reactions against retinal antigens in clinical disease. Curr Eye Res 9 (Suppl.): 85-89.
42. Klaren VN, Peek R 2001. Evidence for a compartmentalized B cell response as characterized by IgG epitope specificity in human ocular toxoplasmosis. J Immunol 167: 6263-6269.
43. Klass M, Böhnke M, Damms T, Knospe V 1991. Humoral immune response to retinal S-antigen in patients with uveitis. Fortschr Ophthalmol 88: 450-454.
44. Knight BC, Brunton CL, Modi NC, Wallace GR, Stanford MR 2005. The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. J Neuroimmunol 160: 41-47.
45. Knight BC, Kissane S, Falciani F, Salmon M, Stanford MR, Wallace GR 2006. Expression analysis of immune response genes of Müller cells infected with Toxoplasma gondii. J Neuroimmunol 179: 126-131.
46. Kryczek I, Wei S, Vatan L, Escara-Wilke J, Szeliga W, Keller ET, Zou W 2007. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol 179: 1423-1426.
47. Lee HO, Herndon JM, Barreiro R, Griffith TS, Ferguson TA 2002. TRAIL: a mechanism of tumor surveillance in an immune privileged site. J Immunol 169: 4739-4744.
48. Lee WR, Hay J, Hutchison WM, Dutton GN, Siim JC 1983. A murine model of congenital toxoplasmic retinochoroiditis. Acta Ophthalmol (Copenh) 61: 818-830.
49. Lu F, Huang S, Hu MS, Kasper LH 2005. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect Immun 73: 5160-5165.
50. Lu F, Huang S, Kasper LH 2003. Interleukin-10 and pathogenesis of murine ocular toxoplasmosis. Infect Immun 71: 7159-7163.
51. Lu F, Huang S, Kasper LH 2004. CD4(+) T cells in the pathogenesis of murine ocular toxoplasmosis. Infect Immun 72: 4966-4972.
52. Luger D, Caspi RR 2008. New perspectives on effector mechanism in uveitis. Semin Immunopathol 30: 135-143.
53. Lyons RE, Anthony JP, Ferguson DJ, Byrne N, Alexander J, Roberts F, Roberts CW 2001. Immunological studies of chronic ocular toxoplasmosis: up-regulation of major histocompatibility complex class I and transforming growth factor beta and a protective role for interleukin-6. Infect Immun 69: 2589-2595.
54. Matsumura Y, Kobayashi T, Ichiyama K, Yoshida R, Hashimoto M, Takimoto T, Tanaka K, Chinen T, Shichita T, Wyss-Coray T, Sato K, Yoshimura A 2007. Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol 179: 2170-2179.
55. McKenzie BS, Kastelein RA, Cua DJ 2006. Understanding the IL-23- IL-17 immune pathway. Trends Immunol 27: 17-23.
56. Miller R, Wen X, Dunford B, Wang X, Suzuki Y 2006. Cytokine production of CD8+immune T cells but not of CD4(+) T cells from Toxoplasma gondii-infected mice is polarized to a type 1 response following stimulation with tachyzoite-infected macrophages. J Interferon Cytokine Res 26: 787-792.
57. Mordue DG, Monroy F, La Regina M, Dinarello CA, Sibley LD 2001. Acute toxoplasmosis leads to lethal overproduction of T(H)-1 cytokines. J Immunol 167: 4574-4584.
58. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H 2007. Reciprocal T(H)-17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260.
59. Muiño JC, Juárez CP, Luna JD, Castro CC, Wolff EG, Ferrero M, Romero-Piffiguer MD 1999. The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis. J Clin Immunol 19: 215-222.
60. Murray PI, Hoekzema R, van Haren MA, de Hon FD, Kijlstra A 1990. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 31: 917-920.
61. Nagineni CN, Detrick B, Hooks JJ 2000. Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL- 6, granulocyte-macrophage colony-stimulating factor, and inter-cellular adhesion molecule 1 by human retinal pigment epithelial cells. Infect Immun 68: 407-410
62. Nagineni CN, Detrick B, Hooks JJ 2002. Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clin Exp Immunol 128: 372-378.
63. Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ 1996. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun 64: 4188-4196.
64. Neufert C, Becker C, Wirtz S, Fantini MC, Weigmann B, Galle PR, Neurath MF 2007. IL-27 controls the development of inducible regulatory T cells and T(H)-17 cells via differential effects on STAT1. Eur J Immunol 37: 1809-1816.
65. Norose K, Mun HS, Aosai F, Chen M, Piao LX, Kobayashi M, Iwakura Y, Yano A 2003. IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye. Invest Ophthalmol Vis Sci 44: 4375-4381.
66. Nussenblatt RB, Mittal KK, Fuhrman S, Sharma SD, Palestine AG 1989. Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol 107: 632-641.
67. O'Connor GR. Factors related to the initiation and recurrence of uveitis 1983. XL Edward Jackson memorial lecture. Am J Ophthalmol 96: 577-599.
68. Oh JO, O'Connor GR 1971. Effects of an interferon inducer, poly I:C, on acute ocular infection produced by intracameral inoculation of Toxoplasma gondii. Infect Immun 4: 407-410.
69. Ohno S, O'Connor GR, Kimura SJ 1977. HLA antigens and toxoplasmic retinochoroiditis. Tohoku J Exp Med 123: 91-94.
70. Ongkosuwito JV, Feron EJ, van Doornik CE, Van der Lelij A, Hoyng CB, La Heij EC, Kijlstra A 1998. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci 39: 2659-2665.
71. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
72. Pereira Mde F, Silva DA, Ferro EA, Mineo JR 1999. Acquired and congenital ocular toxoplasmosis experimentally induced in Calomys callosus (Rodentia, Cricetidae). Mem Inst Oswaldo Cruz 94: 103-114.
73. Rahi AH, Addison DJ 1983. Autoimmunity and the outer retina. Trans Ophthalmol Soc UK 103: 428-437.
74. Roberts F, McLeod R 1999. Pathogenesis of toxoplasmic retinochoroiditis. Parasitol Today 15: 51-57.
75. Romagnani S 2008. Human T(H)-17 cells. Arthritis Res Ther 10: 206.
76. Sergent V, Cautain B, Khalife J, Deslée D, Bastien P, Dao A, Dubremetz JF, Fournié GJ, Saoudi A, Cesbron-Delauw MF 2005. Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells. Infect Immun 73: 6990-6997.
77. Shen DF, Matteson DM, Tuaillon N, Suedekum BK, Buggage RR, Chan CC 2001. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis. Invest Ophthalmol Vis Sci 42: 2031-2036.
78. Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, Villarino AV, Huang Q, Yoshimura A, Sehy D, Saris CJ, O'Shea JJ, Hennighausen L, Ernst M, Hunter CA 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7: 937-945.
79. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8: 1363-1371.
80. Sugita S, Taguchi C, Takase H, Sagawa K, Sueda J, Fukushi K, Hikita N, Watanabe T, Itoh K, Mochizuki M 2000. Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis. Br J Ophthalmol 84: 1130-1134.
81. Takeuchi M, Keino H, Kezuka T, Usui M, Taguchi O 2004. Immune responses to retinal self-antigens in CD25(+)CD4(+) regulatory T-cell-depleted mice. Invest Ophthalmol Vis Sci 45: 1879-1886.
82. Vallochi AL, da Silva Rios L, Nakamura MV, Silveira C, Muccioli C, Martins MC, Belfort R Jr, Rizzo LV 2005. The involvement of autoimmunity against retinal antigens in determining disease severity in toxoplasmosis. J Autoimmun 24: 25-32.
83. Villarino AV, Stumhofer JS, Saris CJ, Kastelein RA, de Sauvage FJ, Hunter CA 2006. IL-27 limits IL-2 production during T(H)-1 differentiation. J Immunol 176: 237-247.
84. Wang J, Wang G, Sun B, Li H, Mu L, Wang Q, Li G, Shi L, Jin L, Kostulas N 2008. Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment. J Autoimmun 30: 222-229.
85. Wang X, Suzuki Y 2007. Microglia produce IFN-gamma independently from T cells during acute toxoplasmosis in the brain. J Interferon Cytokine Res 27: 599-605.
86. Welter A, Mineo JR, de Oliveira Silva DA, Lourenço EV, Vieira Ferro EA, Roque-Barreira MC, Maria da Silva N 2007. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites. Int J Exp Pathol 88: 325-335.
87. Whittle RM, Wallace GR, Whiston RA, Dumonde DC, Stanford MR 1998. Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol 82: 1017-1021.
88. Wyler DJ, Blackman HJ, Lunde MN 1980. Cellular hypersensitivity to toxoplasmal and retinal antigens in patients with toxoplasma retinochoroiditis. Am J Trop Med Hyg 29: 1181-1186.
89. Yagi J, Arimura Y, Takatori H, Nakajima H, Iwamoto I, Uchiyama T 2006. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naïve CD4(+) T cells. Int Immunol 18: 1681-1690.
90. Yap GS, Sher A 1999. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 201: 240-247.
91. Zhang H, Yang P, Zhou H, Meng Q, Huang X 2008. Involvement of Foxp3-expressing CD4(+) CD25+regulatory T cells in the development of tolerance induced by transforming growth factor-beta2-treated antigen-presenting cells. Immunology 124: 304-314.